Twitter

Archive for April 12th, 2012


Prostate Cancer and Treatments Causes Of Erectile Dysfunction

www.artsina.com — The Conventional Causes Of Erectile Dysfunction Prostate Cancer and Treatments… up to 90% of men who undergo total removal of the prostate and about 75% of those who have had radiation treatment for prostate cancer experience erectile dysfunction afterward. The problem is that advanced stages of prostate cancer often damage nerves needed for erectile function. Luckily, you can access a free solution to surgery and drug treatments below. Read More… Visit Website www.artsina.com

Read More...

A Safety/Feasibility Trial of the Addition of the Humanized Anti-GD2 Antibody (hu14.18K322A) With and Without Natural Killer Cells to Chemotherapy in Children and Adolescents With Recurrent/Refractory Neuroblastoma

Condition :   Neuroblastoma Interventions :   Biological: Humanized anti-GD2 antibody;   Drug: Chemotherapy;   Other: Cytokines;   Biological: Natural killer cells Sponsor :   St. Jude Children’s Research Hospital Recruiting – verified April 2012

Read More...

Elders Preferences in Care Decisions

Conditions :   Early Detection of Cancer;   Colon Cancer;   Decision Making;   Patient-Centered Care Interventions :   Behavioral: Making A Decision About CRC Screening;   Behavioral: Drivers 65 Plus Sponsors :   University of North Carolina, Chapel Hill;   Duke University;   Agency for Healthcare Research and Quality (AHRQ) Enrolling by invitation – verified April 2012

Read More...

Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer

Condition :   Prostatic Neoplasms Interventions :   Drug: CABAZITAXEL (XRP6258);   Drug: DOCETAXEL (XRP6976) Sponsor :   Sanofi-Aventis Not yet recruiting – verified April 2012

Read More...

Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients

Condition :   Advanced Cancer Interventions :   Drug: crizotinib;   Drug: crizotinib;   Drug: crizotinib;   Drug: crizotinib;   Drug: crizotinib Sponsor :   Pfizer Not yet recruiting – verified April 2012

Read More...

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function

Condition :   Multiple Myeloma Interventions :   Drug: Oral Pomalidomide (POM) and Oral Dexamethasone (LD-DEX) (Cohort A);   Drug: Oral Pomalidomide (POM) and Oral Dexamethasone (LD-DEX) (Cohort B) Sponsor :   Celgene Corporation Not yet recruiting – verified April 2012

Read More...

A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

Conditions :   Adenocarcinoma, Scirrhous,;   Linitis Plastica;   Stomach Neoplasms,;   Stomach Diseases,;   Neoplasms by Site;   Neoplasms Intervention :   Drug: TKI258 Sponsor :   Novartis Pharmaceuticals Not yet recruiting – verified April 2012

Read More...

MOTIVACTION – Study

Condition :   Cancer Interventions :   Other: Exercise counseling (behavior change techniques);   Other: Stress-management training Sponsors :   German Cancer Research Center;   University of Heidelberg Not yet recruiting – verified April 2012

Read More...

Maintenance Lenalidomide in Lymphoma

Condition :   Lymphoma Intervention :   Drug: Lenalidomide Sponsor :   Abramson Cancer Center of the University of Pennsylvania Recruiting – verified April 2012

Read More...

The Management of Postoperative Craniotomy Pain in Pediatric Patients

Conditions :   Post Craniotomy Surgery;   Cancer;   Epilepsy;   Vascular Malformations;   Craniofacial Reconstructive Surgery Intervention :   Sponsor :   Johns Hopkins University Enrolling by invitation – verified April 2012

Read More...